OS Therapies (OSTX) Total Debt (2023 - 2026)
OS Therapies (OSTX) reported Total Debt of $1.34 million for Q1 2026.
Powered by 
Analysis
OS Therapies (OSTX) Total Debt (2023 - 2026) Analysis & Trends
At the end of FY2023, OS Therapies posted Total Debt of $16.64 million.
- The Q1 2026 figure ranks as the highest quarterly Total Debt since Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 49.04 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 63.19 Bn |
| 10 | OS Therapies | 6.11 Mn | 2.84 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.34 Mn |
| Jun 30, 2024 | 16.70 Mn |
| Mar 31, 2024 | 17.74 Mn |
| Dec 31, 2023 | 16.64 Mn |
API Access
OS Therapies Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=OSTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "OSTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=OSTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();